NCT06073769View on ClinicalTrials.gov

A Post-Marketing Surveillance Study to Assess the Safety of Oral Azacitidine Maintenance Therapy in Korean Patients With Acute Myeloid Leukemia

RecruitingOBSERVATIONAL
Enrollment

154

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

July 30, 2027

Study Completion Date

July 30, 2027

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Oral azacitidine

Maintenance therapy according to the approved label

Trial Locations (2)

06234

TERMINATED

Local Institution - 0001, Seoul

RECRUITING

Novotech Laboratory Korea Co., Ltd., Seoul

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY